Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Joanna Jasinska"'
Autor:
Lukas Richter, Daniela Schmid, Elisabeth Eva Kanitz, Ines Zwazl, Eva Pöllabauer, Joanna Jasinska, Heinz Burgmann, Michael Kundi, Ursula Wiedermann
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210081 (2019)
BackgroundIn February 2012 the ten-valent pneumococcal conjugate vaccine (PCV10) with a 2+1 doses schedule (3, 5, 12 or 14 months of age) without catch-up vaccination was introduced in Austria. We assessed direct and indirect vaccine effects on invas
Externí odkaz:
https://doaj.org/article/c9322b5b10044468bd32f23e61bdf0c3
Autor:
Lukas Richter, Daniela Schmid, Elisabeth Eva Kanitz, Ines Zwazl, Eva Pöllabauer, Joanna Jasinska, Heinz Burgmann, Michael Kundi, Ursula Wiedermann
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212957 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0210081.].
Externí odkaz:
https://doaj.org/article/b23e4d75bb744cabbbffc5a771b3138d
Autor:
Elisabeth Hoflehner, Karin Hufnagl, Irma Schabussova, Joanna Jasinska, Karin Hoffmann-Sommergruber, Barbara Bohle, Rick M Maizels, Ursula Wiedermann
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39409 (2012)
Among birch pollen allergic patients up to 70% develop allergic reactions to Bet v 1-homologue food allergens such as Api g 1 (celery) or Dau c 1 (carrot), termed as birch pollen-related food allergy. In most cases, specific immunotherapy with birch
Externí odkaz:
https://doaj.org/article/896d1fad48134240a8c36cdab56ba2f9
Publikováno v:
Eurosurveillance. 28
Following an increase in diphtheria cases in Europe since 2022, we retrospectively estimated the prevalence of seroprotection against diphtheria and tetanus in 10,247 Austrian residents (population: 8,978,929) voluntarily tested between 2018 and 2022
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e3da3a335ba303ecf3f998007e74e92
https://doi.org/10.2807/1560-7917.es.2023.28.17.2300206
https://doi.org/10.2807/1560-7917.es.2023.28.17.2300206
Publikováno v:
Vaccine
Patients undergoing immunosuppressive treatments have a higher need for protection against coronavirus disease (COVID19) that follows infection with the SARS-CoV-2 virus but their ability to respond sufficiently to COVID vaccines is uncertain. We ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23563973d33e07174b91cfe80dfcea26
https://doi.org/10.1016/j.vaccine.2021.10.068
https://doi.org/10.1016/j.vaccine.2021.10.068
Autor:
Joanna Jasinska
Publikováno v:
Archives in Neurology & Neuroscience. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197f4d2088071f2d42f7abf93a44bb7d
https://doi.org/10.33552/ann.2022.12.000785
https://doi.org/10.33552/ann.2022.12.000785
Autor:
Joanna Jasinska, Ute Scheikl, Angela Guzek, Thomas R. Kreil, Eva Hoeltl, Johanna Ruff, Maria R. Farcet, Ursula Wiedermann, Hannes Stockinger, Ines Zwazl, Michael Kundi, Angelika Wagner
Publikováno v:
Communications medicine. 1
In spring 2020, at the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Europe, we set up an assay system for large-scale testing of virus-specific and neutralising antibodies including their longevity. We ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d0daf4fcf9d65a72a1e1fe33312173
https://pubmed.ncbi.nlm.nih.gov/35602189
https://pubmed.ncbi.nlm.nih.gov/35602189
Autor:
Hannes Stockinger, Angelika Wagner, Maria R. Farcet, Thomas R. Kreil, Joanna Jasinska, Ines Zwazl, Michael Kundi, Ursula Wiedermann, Johanna Ruff, Ute Scheikl, Eva Hoeltl, Angela Guzek
BackgroundIn spring 2020, at the beginning of the first pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wave in Europe, we set up an assay system for large-scale testing of virus-specific and protective antibodies including thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f467b43b9afd9d382965927c1aa9d0d2
https://doi.org/10.1101/2020.12.22.20248604
https://doi.org/10.1101/2020.12.22.20248604
Autor:
Joanna Jasinska
Publikováno v:
Frontiers in Medical Case Reports.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::538c8909eefd8fa4b29d4354a4c81b21
https://doi.org/10.47746/fmcr.2020.1104
https://doi.org/10.47746/fmcr.2020.1104
Autor:
Joshua Tobias1, Joanna Jasinska1, Karin Baier1, Michael Kundi2, Nicholas Ede3, Christoph Zielinski4, Ursula Wiedermann1 ursula.wiedermann@meduniwien.ac.at, Tobias, Joshua5 (AUTHOR), Jasinska, Joanna5 (AUTHOR), Baier, Karin5 (AUTHOR), Kundi, Michael6 (AUTHOR), Ede, Nicholas7 (AUTHOR), Zielinski, Christoph4 (AUTHOR), Wiedermann, Ursula5 (AUTHOR)
Publikováno v:
BMC Cancer. 2/9/2017, Vol. 17, p1-13. 13p. 1 Diagram, 2 Charts, 7 Graphs.